Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

Clinical trial NCT05681195 · RECRUITING

Trial details

NCT number: NCT05681195
Sponsor: Baptist Health South Florida
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Central Nervous System Lymphoma Secondary Central Nervous System Lymphoma Relapsed Cancer Refractory Cancer

Start date: 2024-04-25
Primary completion: 2028-02-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.